StephanLadischMD
Pediatric Hematology & Oncology • Washington, DCPediatric Hematologic Oncology, Pediatric Solid Tumor Oncology
Professor, Pediatrics, G Washington University School of Medicine & Hlth Sci
Dr. Ladisch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave NW
Washington, DC 20010Phone+1 202-884-2140Fax+1 301-572-3544
Education & Training
National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 1975 - 1978
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1974 - 1975- Boston Children’s Hospital/Boston Medical CenterInternship, Pediatrics, 1973 - 1974
Perelman School of Medicine at the University of PennsylvaniaClass of 1973
Certifications & Licensure
DC State Medical License 1992 - 2024
MD State Medical License 1976 - 2023- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell
Cancer. 2024-07-15 - 20 citationsIFN-γ Signature in the Plasma Proteome Distinguishes Pediatric Hemophagocytic Lymphohistiocytosis from Sepsis and SIRSHoward Lin, Brooks Scull, Baruch Goldberg, Harshal Abhyankar, Olive E. Eckstein
Blood Advances. 2021-09-14 - 64 citationsT-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsisVandana Chaturvedi, Rebecca A. Marsh, Adi Zoref-Lorenz, Erika Owsley, Vijaya Chaturvedi
Blood. 2021-04-29
Press Mentions
Longer Treatment for Children with Langerhans Cell Hystiocytosis Improves Survival RatesJanuary 29th, 2016
Grant Support
- Role Of Gangliosides In Tumor ProgressionNational Cancer Institute2009–2011
- Complex Ganglioside Function In NeuroblastomaNational Cancer Institute2006–2008
- Gangliosides And The Biology Of Human NeuroblastomaNational Cancer Institute2004–2008
- Glycobiology Of Human MedulloblastomaNational Cancer Institute1998–2008
- Child Health Research Career Development AwardEunice Kennedy Shriver National Institute Of Child Health &Human Development2001
- Immunosuppressive Neuroblastoma Tumor GangliosidesNational Cancer Institute1996–2000
- Glycobiology Of Human MedulloblastomaNational Center For Research Resources1999
- Immunosuppressive Neuroblastoma Tumor GangliosidesNational Center For Research Resources1996–1999
- Ganglioside On Primitive Neuroectodermal Tumor Biology Of Human MedulloblastomaNational Center For Research Resources1997
- Glycobiology Of Human MedulloblastomaNational Cancer Institute1993–1997
- Glycosphingolipid Biology Of Human Medulloblastoma Identify Active MoleculesNational Center For Research Resources1996
- Glycobiology Of MedulloblastomaNational Cancer Institute1994
- Immunosuppressive Neuroblastoma Tumor GangliosidesNational Cancer Institute1991–1992
- Immunosuppressive Neuroblastoma Tumor GangliosidesNational Cancer Institute1986–1991
- Immunoregulatory Functions Of GangliosidesNational Cancer Institute1985–1986
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
